Toripalimab, identified chemically as compound 1924598-82-2, represents a engineered clonable antibody engineered to engage PD-1, an immunologic checkpoint molecule. Its mechanism of operation involves preventing the https://toripalimab-antibody286274.blog-gold.com/profile